Coronary artery disease and prevention of heart failure

Liviu Klein*, Mihai Gheorghiade

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Coronary artery disease and its progression are major contributors to the development and progression of left ventricular systolic dysfunction and HF. This progression does not require a discrete coronary event such as an acute myocardial infarction because chronic ischemia may contribute, as well. In addition, endothelial dysfunction may also lead to progression of myocardial dysfunction. Measures specifically targeting reduction in the risk of reinfarction and improvement in endothelial function may play an important role in blunting the progression of HF and in improving prognosis. Recognizing that coronary artery disease is a leading cause of HF in the United States is of critical importance if mortality from this condition is to be reduced. Although some patients may be candidates for mechanical revascularization (coronary artery bypass surgery or percutaneous coronary intervention) to improve left ventricular function, all patients are candidates for aggressive secondary prevention strategies (pharmacologic revascularization) designed to reduce progression of coronary artery disease.

Original languageEnglish (US)
Pages (from-to)1209-1235
Number of pages27
JournalMedical Clinics of North America
Volume88
Issue number5
DOIs
StatePublished - Sep 1 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Coronary artery disease and prevention of heart failure'. Together they form a unique fingerprint.

Cite this